http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0558891-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c2477bdea308bc9dec3feded37457 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 |
| filingDate | 1991-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e644f96ff290d1ca570079cc4164a3ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_593e947d650f03ef613267dc97074bf3 |
| publicationDate | 1993-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H0558891-A |
| titleOfInvention | Atherosclerosis treatment / prevention agent |
| abstract | (57) [Summary] [Purpose] To provide a therapeutic / preventive agent for arteriosclerosis. The present invention relates to a therapeutic / preventive agent for arteriosclerosis represented by the following general formula. [Chemical 1] When this compound is added to LDL and oxidized with various oxidants, the formation of phosphatidylcholine and cholesterol peroxidase can be suppressed, and it is considered to be an excellent therapeutic / preventive agent for arteriosclerosis. Be done. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11006626-B2 |
| priorityDate | 1991-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.